KIEV, Jan. 20 – No clear explanations regarding the mechanism of price referencing and a reimbursement system in Ukraine could lead to a shortage of medicines, depriving patients of vital drugs, according to the European Business Association.

"We ask to ensure posting the official explanation of the Cabinet of Ministers with respect to the possibility of acquiring any drugs by patients from the list of 21 INNs (International Nonproprietary Name) at their own expense in case of non-refunds of their value by the state," reads an open letter from the EBA to Prime Minister Volodymyr Groysman, Cabinet Minister Oleksandr Sayenko and acting Health Minister Ulana Suprun.